Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Not applicable.

SCHEDULE II

AMPHENOL CORPORATION AND SUBSIDIARIES

VALUATION AND QUALIFYING ACCOUNTS

For the years ended December 31, 2017, 2016 and 2015

(Dollars in millions)

Balance atCharged toBalance at
beginningcost andAdditionsend of
of periodexpenses(Deductions)period
Allowance for doubtful accounts:
Year ended 2017$23.6$1.8$(2.4)$23.0
Year ended 201625.66.0(8.0)23.6
Year ended 201520.23.71.725.6
Valuation allowance on deferred tax assets:
Year ended 2017$37.2$2.5$(0.1)$39.6
Year ended 201618.54.813.937.2
Year ended 201515.53.0—18.5

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the Town of Wallingford, State of Connecticut on the 21st day of February, 2018.

AMPHENOL CORPORATION
/s/ R. Adam Norwitt
R. Adam Norwitt
President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated below.

SignatureTitleDate
/s/ R. Adam NorwittPresident and Chief Executive OfficerFebruary 21, 2018
R. Adam Norwitt(Principal Executive Officer)
/s/ Craig A. LampoSenior Vice President and Chief Financial OfficerFebruary 21, 2018
Craig A. Lampo(Principal Financial Officer and Principal Accounting Officer)
/s/ Martin H. LoefflerChairman of the Board of DirectorsFebruary 21, 2018
Martin H. Loeffler
/s/ Ronald P. BadieDirectorFebruary 21, 2018
Ronald P. Badie
/s/ Stanley L. ClarkDirectorFebruary 21, 2018
Stanley L. Clark
/s/ John D. CraigDirectorFebruary 21, 2018
John D. Craig
/s/ David P. FalckDirectorFebruary 21, 2018
David P. Falck
/s/ Edward G. JepsenDirectorFebruary 21, 2018
Edward G. Jepsen
/s/ John R. LordDirectorFebruary 21, 2018
John R. Lord
/s/ Diana G. ReardonDirectorFebruary 21, 2018
Diana G. Reardon

Previous: Item 15. Exhibits, Financial Statement Schedules